How Pfizer's $43B acquisition of Seagen may impact Seattle and broader biotech market - GeekWire
geekwire.comSubmitted by geekwire4894 in business
William Canestaro. (LinkedIn Photo) Editor's note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the